Abstract
Assessment of magnetic resonance imaging (MRI) after neoadjuvant chemoradiation therapy (nCRT) is essential in rectal cancer staging and treatment planning. However, when predicting the pathologic complete response (pCR) after nCRT for rectal cancer, existing works either rely on simple quantitative evaluation based on radiomics features or partially analyze multi-parametric MRI. We propose an effective pCR prediction method based on novel multi-parametric MRI embedding. We first seek to extract volumetric features of tumors that can be found only by analyzing multiple MRI sequences jointly. Specifically, we encapsulate multiple MRI sequences into multi-sequence fusion images (MSFI) and generate MSFI embedding. We merge radiomics features, which capture important characteristics of tumors, with MSFI embedding to generate multi-parametric MRI embedding and then use it to predict pCR using a random forest classifier. Our extensive experiments demonstrate that using all given MRI sequences is the most effective regardless of the dimension reduction method. The proposed method outperformed any variants with different combinations of feature vectors and dimension reduction methods or different classification models. Comparative experiments demonstrate that it outperformed four competing baselines in terms of the AUC and F1-score. We use MRI sequences from 912 patients with rectal cancer, a much larger sample than in any existing work.
Highlights
Rectal cancer is a carcinoma with a high incidence, accounting for 11.4% of the total cancer incidence, with 25,330 new cases in Korea in 2019, according to the Korea Central Cancer Registry [1]
We propose a method for encapsulating multiple magnetic resonance imaging (MRI) sequences into an multi-sequence fusion images (MSFI) and generating MSFI embedding using 3D-convolutional neural network (CNN) to extract novel volumetric features of tumors
We demonstrated the superiority of the proposed method by analyzing its pathologic complete response (pCR) prediction performance and comparing it with competing baselines based on a large cohort of 912 rectal cancer patients
Summary
Rectal cancer is a carcinoma with a high incidence, accounting for 11.4% of the total cancer incidence, with 25,330 new cases in Korea in 2019, according to the Korea Central Cancer Registry [1]. For locally advanced rectal cancer, neoadjuvant chemoradiation therapy (nCRT) has been suggested to perform chemoradiation therapy before surgery [2]. If we can predict pCR after nCRT accurately through MRI assessment, surgery could be avoided in the case of some patients, thereby greatly improving their quality of life by preserving their organs, which surgery might otherwise damage [3]. Treatments, such as nCRT, may cause fibrosis, desmoplastic reaction, or colloid formation; MRI analysis becomes increasingly challenging
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.